This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
Going by four markers of health risk, four neighboring U.S. states are the best places to raise children with high chances of living long, healthy lives.
A lawsuit claims that nurse staffing levels at Saint Joseph Medical Center in Illinois were too low to meet minimum safety thresholds, resulting in medical errors. Plaintiffs in the case are seeking punitive damages.
The doctor whose ads promise to deliver the “Most Affordable Plastic Surgery Center in Chicago. Period.” was hit with a $56 million civil judgment in 2025 but is still practicing medicine in multiple states.
Many patients mistake auto-text messages from providers as opportunities to interact with the sender. When this happens, the patient often tries to communicate about more than just appointment scheduling.
The buyout, announced last summer, drew the attention of federal regulators at the Federal Trade Commission, concerned that competition for ambulatory surgery services would be stifled by the merger. To appease the agency, Ascension has agreed to divest from some centers previously owned by Amsurg.
Hospitals should be making every effort to help sonographers deliver better, more accurate echocardiograms and improve the diagnosis of severe aortic stenosis. If you take care of your sonographers, your sonographers will take care of you.
Valve-in-valve TAVR outperforms redo SAVR for the first six months after treatment, according to a new meta-analysis published in the American Journal of Cardiology. Then, however, things begin to shift.
At a time when patient assaults against nurses are reportedly on the rise, cases that invert the equation only reinforce the public’s perception that hospitals are chaotic places.
“We can reach tissues, bones and organs with high spatial precision that haven’t been reachable with light-based printing methods," one researcher explained.
The popular SGLT2 inhibitor, sold under the brand name Farxiga, is approved by the FDA to treat heart failure, type 2 diabetes and CKD. Recent data on its ability to affect the symptoms of heart failure patients have been inconsistent.
In its annual outlook report released this week, Fitch Ratings says the coming calendar year will probably strike much of the sector as “another make or break” period.